Enhanced influenza vaccines impact effectiveness in individuals aged 65 years and older, Denmark, 2024/25 influenza season up to 4 March 2025
Hanne‐Dorthe Emborg(Statens Serum Institut), Bolette Søborg(Statens Serum Institut), Amanda Bolt Botnen(Statens Serum Institut), Palle Valentiner‐Branth(Statens Serum Institut), Ramona Trebbien(Ministry of External Affairs), Tyra Grove Krause(Statens Serum Institut)
Cited by 12
Related Papers
Effect of Abolishment of the Use of Antimicrobial Agents for Growth Promotion on Occurrence of Antimicrobial Resistance in Fecal Enterococci from Food Animals in Denmark
|Antimicrobial Agents and Chemotherapy|2001|653
Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort
|International Journal of Epidemiology|2020|280
Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020
|Eurosurveillance|2020|238
Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study
|The Lancet Infectious Diseases|2022|218